ACTUATE THERAPEUTICS, INC.

Profile

Company Names

ACTUATE THERAPEUTICS, INC.

Addresses

1751 RIVER RUN, SUITE 400, FORT WORTH, TX 76107

1401 FOCH STREET, FORT WORTH, TX 76107

1401 FOCH STREET, SUITE 140, FORT WORTH, TX 76107

Phone Numbers

817-984-5964
847-986-4190

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$77,456,104.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2025-06-27 
$4,665,479.00 
$9,330,958.00 
$4,665,479.00 
Equity 
9
2024-02-20 
$3,000,000.00 
$5,000,000.00 
$2,000,000.00 
Debt 
8
2022-09-30 
$19,336,491.00 
$50,000,000.00 
$30,663,509.00 
Equity 
7
2020-11-30 
$14,482,301.00 
$50,000,000.00 
$35,517,699.00 
Equity 
6
2019-10-01 
$6,500,000.00 
$6,500,000.00 
$0.00 
Equity 
5
2019-04-30 
$21,886,833.00 
$23,952,152.00 
$2,065,319.00 
Equity 
4
2018-08-28 
$4,025,000.00 
$4,025,000.00 
$0.00 
Debt 
3
2017-03-17 
$3,000,000.00 
$5,000,000.00 
$2,000,000.00 
Equity 
2
2017-01-18 
$150,000.00 
$150,000.00 
$0.00 
Debt 
1
2015-09-29 
$410,000.00 
$500,000.00 
$90,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALEX 
 
ANDRIANOPOULOS 
DIRECTOR
KAPTEYN-MURNANE LABORATORIES, INC.   |  INTEGRA DEVICES, INC.   |  ACTUATE THERAPEUTICS, INC.   |  APPLAUD MEDICAL, INC.   |  NOVOSTEO INC.   |  VIVODYNE, INC.   |  AVVIO MEDICAL, INC.
NEIL 
 
BAJPAYEE 
DIRECTOR
ACTUATE THERAPEUTICS, INC.
AARON 
 
FLETCHER 
DIRECTOR
LUNG THERAPEUTICS, INC.   |  COGNITION THERAPEUTICS INC   |  BIOS LTI SPV II, LP   |  TFF PHARMACEUTICALS, INC.   |  ABILITECH MEDICAL, INC.   |  XY GAMING, INC.   |  CUE BIOPHARMA, INC.   |  BIOS SPECIAL OPPORTUNITY FUND II, LP   |  ACTUATE THERAPEUTICS, INC.   |  ONL THERAPEUTICS, INC.
AARON 
G.L. 
FLETCHER 
DIRECTOR
LUNG THERAPEUTICS, INC.   |  BIOS SPECIAL OPPORTUNITY FUND, LP   |  BIOS ACTUATE CO-INVEST III, LP   |  BIOS CLINICAL OPPORTUNITY FUND, LP   |  BIOS 2024 CO-INVEST, LP   |  BIOS ONL CO-INVEST II, LP   |  ACTUATE THERAPEUTICS, INC.
AARON 
GLENN LOUIS 
FLETCHER 
DIRECTOR, PROMOTER
BIOS MEMORY SPV I, LP   |  ACTUATE THERAPEUTICS, INC.   |  BIOS LTI SPV II, LP   |  BIOS OMI SPV I, LP   |  BIOS FUND I, LP   |  BIOS FUND I QP, LP   |  BIOS FUND II, LP   |  BIOS FUND II QP, LP   |  BIOS FUND II NT, LP   |  BIOS INCYSUS CO-INVEST I, LP   |  BIOS IMMUSOFT CO-INVEST I, LP   |  BIOS AZITRA CO-INVEST I, LP   |  BIOS LTI CO-INVEST III, LP   |  BIOS LTI CO-INVEST III QP, LP   |  BIOS FUND III NT, LP   |  BIOS FUND III QP, LP   |  BIOS FUND III, LP   |  BIOS SIRPANT CO-INVEST I, LP   |  BIOS SIRPANT CO-INVEST I QP, LP   |  BIOS I-LUMEN CO-INVEST I, LP
AARON GLENN 
LOUIS 
FLETCHER 
DIRECTOR
ACTUATE THERAPEUTICS, INC.
JASON 
 
KEYES 
DIRECTOR
OREXIGEN THERAPEUTICS, INC.   |  ACTUATE THERAPEUTICS, INC.
LESLIE 
WAYNE 
KREIS JR. 
DIRECTOR
ACTUATE THERAPEUTICS, INC.   |  BIOS ACTUATE CO-INVEST III, LP
LESLIE 
 
KREIS, JR. 
DIRECTOR
ACTUATE THERAPEUTICS, INC.
LESLIE 
WAYNE 
KREIS, JR. 
DIRECTOR, PROMOTER
SCM VISION, LP   |  SCM KUTOA SPV I, LP   |  BIOS MEMORY SPV I, LP   |  BIOS VISION SPV II, LP   |  ACTUATE THERAPEUTICS, INC.   |  BIOS LTI SPV II, LP   |  BIOS MEMORY SPV II, LP   |  BIOS FUND I, LP   |  BIOS FUND I QP, LP   |  BIOS FUND II, LP   |  BIOS FUND II QP, LP   |  BIOS FUND II NT, LP   |  BIOS INCYSUS CO-INVEST I, LP   |  BIOS IMMUSOFT CO-INVEST I, LP   |  BIOS AZITRA CO-INVEST I, LP   |  BIOS LTI CO-INVEST III, LP   |  BIOS LTI CO-INVEST III QP, LP   |  BIOS FUND III NT, LP   |  BIOS FUND III QP, LP   |  BIOS FUND III, LP   |  BIOS SIRPANT CO-INVEST I, LP   |  BIOS SIRPANT CO-INVEST I QP, LP
PASCAL 
 
KROTEE 
DIRECTOR
ACTUATE THERAPEUTICS, INC.   |  NOVOSTEO INC.   |  BLUEJAY THERAPEUTICS, INC.
PAUL 
 
LYTLE 
EXECUTIVE OFFICER
ACTUATE THERAPEUTICS, INC.
ANDREW 
 
MAZAR 
EXECUTIVE OFFICER
ACTUATE THERAPEUTICS, INC.
AMY 
 
RONNEBERG 
DIRECTOR
MAGENTA THERAPEUTICS, INC.   |  ACTUATE THERAPEUTICS, INC.
ROGER 
 
SAWHNEY 
DIRECTOR
ARCELLX, INC.   |  SIRPANT IMMUNOTHERAPEUTICS, INC.   |  BOBCATBIO, INC.   |  ACTUATE THERAPEUTICS, INC.
DANIEL 
 
SCHMITT 
EXECUTIVE OFFICER, DIRECTOR
RF CONTROLS LLC   |  ACTUATE THERAPEUTICS, INC.
DANIEL 
M 
SCHMITT 
EXECUTIVE OFFICER, DIRECTOR
ACTUATE THERAPEUTICS, INC.
DANIEL 
M. 
SCHMITT 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
ACTUATE THERAPEUTICS, INC.
TODD 
 
THOMSON 
DIRECTOR
CYREN LTD.   |  ACTUATE THERAPEUTICS, INC.   |  CENTURY FINANCIAL SERVICES CORP   |  ZOOZ POWER LTD.   |  LINNAEUS THERAPEUTICS, INC.   |  SCN CANADA, INC.
DAN 
 
ZABROWSKI 
DIRECTOR
OMNIOME, INC.   |  APEXIGEN, INC.   |  ACTUATE THERAPEUTICS, INC.   |  APEXIGEN, INC.
DANIEL 
 
ZABROWSKI 
DIRECTOR
ENDOGENA THERAPEUTICS, INC.   |  ACTUATE THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-07-07
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-06-27 
2024-03-06
D
Link
PHARMACEUTICALS 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Debt 
2024-02-20 
2022-12-15
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-30 
2022-10-19
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-30 
2020-12-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-30 
2019-11-14
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-01 
2019-10-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-01 
2019-05-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-30 
2018-09-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2018-08-28 
2017-03-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-17 
2017-02-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2017-01-18 
2015-10-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2015-09-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NEWBRIDGE SECURITIES CORPORATION
104065